scholarly journals Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double‐blind, phase 3 study

2016 ◽  
Vol 43 (8) ◽  
pp. 869-880 ◽  
Author(s):  
Akihiko Asahina ◽  
Takafumi Etoh ◽  
Atsuyuki Igarashi ◽  
Shinichi Imafuku ◽  
Hidehisa Saeki ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Plaque Psoriasis ◽  
Japanese Patients ◽  
Phase 3 ◽  
Double Blind ◽  
Severe Plaque Psoriasis

Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial

The Lancet ◽  
2019 ◽  
Vol 394 (10198) ◽  
pp. 576-586 ◽  
Author(s):  
Kristian Reich ◽  
Melinda Gooderham ◽  
Diamant Thaçi ◽  
Jeffrey J Crowley ◽  
Caitriona Ryan ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Phase 3 ◽  
Double Blind ◽  
Active Comparator ◽  
Severe Plaque Psoriasis

scholarly journals Efficacy and safety of ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis: Subgroup analysis of a placebo-controlled, phase 3 study (UNCOVER-1)

2017 ◽  
Vol 44 (11) ◽  
pp. 1285-1290 ◽  
Author(s):  
Shinichi Imafuku ◽  
Hitoe Torisu-Itakura ◽  
Atsushi Nishikawa ◽  
Fangyi Zhao ◽  
Gregory S. Cameron ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Subgroup Analysis ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Severe Plaque Psoriasis
Sign in / Sign up

Export Citation Format

Share Document